Versant Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $933K | Buy |
7,713
+206
| +3% | +$24.9K | 0.14% | 81 |
|
|
2025
Q1 | $837K | Buy |
7,507
+6,722
| +856% | +$749K | 0.14% | 87 |
|
|
2024
Q4 | $76.4K | Buy |
785
+696
| +782% | +$67.7K | 0.02% | 409 |
|
|
2024
Q3 | $10.2K | Buy |
89
+74
| +493% | +$8.51K | ﹤0.01% | 1052 |
|
|
2024
Q2 | $1.6K | Hold |
15
| – | – | ﹤0.01% | 1560 |
|
|
2024
Q1 | $1.45K | Sell |
15
-425
| -97% | -$41.1K | ﹤0.01% | 1446 |
|
|
2023
Q4 | $44.4K | Hold |
440
| – | – | 0.01% | 302 |
|
|
2023
Q3 | $44.8K | Hold |
440
| – | – | 0.01% | 281 |
|
|
2023
Q2 | $44.4K | Hold |
440
| – | – | 0.01% | 293 |
|
|
2023
Q1 | $40.5K | Buy |
440
+425
| +2,833% | +$39.1K | 0.01% | 305 |
|
|
2022
Q4 | $1.36K | Hold |
15
| – | – | ﹤0.01% | 1236 |
|
|
2022
Q3 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 1300 |
|
|
2021
Q4 | – | Sell |
-9
| Closed | -$1K | – | 1543 |
|
|
2021
Q3 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 1330 |
|
|
2018
Q1 | – | Sell |
-230
| Closed | -$17K | – | 1604 |
|
|
2017
Q4 | $17K | Buy |
+230
| New | +$17K | 0.01% | 723 |
|
|
2017
Q3 | – | Sell |
-167
| Closed | -$12K | – | 1531 |
|
|
2017
Q2 | $12K | Hold |
167
| – | – | 0.01% | 800 |
|
|
2017
Q1 | $11K | Hold |
167
| – | – | 0.01% | 814 |
|
|
2016
Q4 | $10K | Hold |
167
| – | – | 0.01% | 833 |
|
|
2016
Q3 | $11K | Hold |
167
| – | – | 0.01% | 782 |
|
|
2016
Q2 | $12K | Hold |
167
| – | – | 0.01% | 725 |
|
|
2016
Q1 | $10K | Buy |
+167
| New | +$10K | 0.01% | 765 |
|